133 related articles for article (PubMed ID: 26405464)
1. The Efficacy of One Molar Contrast Material in the Evaluation of Breast Lesions with MR Imaging.
Toprak N; Unal O; Avcu S
Pol J Radiol; 2015; 80():401-10. PubMed ID: 26405464
[TBL] [Abstract][Full Text] [Related]
2. Comparison of gadoteric acid and gadobutrol for detection as well as morphologic and dynamic characterization of lesions on breast dynamic contrast-enhanced magnetic resonance imaging.
Renz DM; Durmus T; Böttcher J; Taupitz M; Diekmann F; Huppertz A; Pfeil A; Maurer MH; Streitparth F; Bick U; Hamm B; Fallenberg EM
Invest Radiol; 2014 Jul; 49(7):474-84. PubMed ID: 24637587
[TBL] [Abstract][Full Text] [Related]
3. Comparison and Optimization of 3.0 T Breast Images Quality of Diffusion-Weighted Imaging with Multiple B-Values.
Han X; Li J; Wang X
Acad Radiol; 2017 Apr; 24(4):418-425. PubMed ID: 27955879
[TBL] [Abstract][Full Text] [Related]
4. Dynamic magnetic resonance imaging of the breast: Comparison of gadobutrol vs. Gd-DTPA.
Escribano F; Sentís M; Oliva JC; Tortajada L; Villajos M; Martín A; Ganau S
Radiologia (Engl Ed); 2018; 60(1):49-56. PubMed ID: 29217300
[TBL] [Abstract][Full Text] [Related]
5. Gadobenate dimeglumine-enhanced MR imaging breast vascular maps: association between invasive cancer and ipsilateral increased vascularity.
Sardanelli F; Iozzelli A; Fausto A; Carriero A; Kirchin MA
Radiology; 2005 Jun; 235(3):791-7. PubMed ID: 15845796
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of gadobutrol versus gadopentetate dimeglumine in enhanced MRI of brain metastases.
Fan B; Li M; Wang X; Xu Y; Li F; Zhang L; Jiang J; Jiang Y
J Magn Reson Imaging; 2017 Jun; 45(6):1827-1834. PubMed ID: 27696616
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of gadobutrol, a macrocyclic, nonionic gadolinium chelate in a brain glioma model: comparison with gadoterate meglumine and gadopentetate dimeglumine at 1.5 T, combined with an assessment of field strength dependence, specifically 1.5 versus 3 T.
Attenberger UI; Runge VM; Morelli JN; Williams J; Jackson CB; Michaely HJ
J Magn Reson Imaging; 2010 Mar; 31(3):549-55. PubMed ID: 20187196
[TBL] [Abstract][Full Text] [Related]
8. Effects of gadobutrol on background parenchymal enhancement and differential diagnosis between benign and malignant lesions in dynamic magnetic resonance imaging of the breast.
Tozaki M; Yabuuchi H; Goto M; Sasaki M; Kubota K; Nakahara H
Breast Cancer; 2021 Jul; 28(4):927-936. PubMed ID: 33625722
[TBL] [Abstract][Full Text] [Related]
9. Breast MR imaging: computer-aided evaluation program for discriminating benign from malignant lesions.
Williams TC; DeMartini WB; Partridge SC; Peacock S; Lehman CD
Radiology; 2007 Jul; 244(1):94-103. PubMed ID: 17507720
[TBL] [Abstract][Full Text] [Related]
10. Macromolecular contrast medium (feruglose) versus small molecular contrast medium (gadopentetate) enhanced magnetic resonance imaging: differentiation of benign and malignant breast lesions.
Daldrup-Link HE; Kaiser A; Helbich T; Werner M; Bjørnerud A; Link TM; Rummeny EJ
Acad Radiol; 2003 Nov; 10(11):1237-46. PubMed ID: 14626298
[TBL] [Abstract][Full Text] [Related]
11. Single-dose gadobutrol in comparison with single-dose gadobenate dimeglumine for magnetic resonance imaging of chronic myocardial infarction at 3 T.
Wildgruber M; Stadlbauer T; Rasper M; Hapfelmeier A; Zelger O; Eckstein HH; Halle M; Rummeny EJ; Huber AM
Invest Radiol; 2014 Nov; 49(11):728-34. PubMed ID: 24872002
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of qualitative and quantitative enhancement parameters on contrast-enhanced mammography.
Kul M; Akkaya S; Kul S
Diagn Interv Radiol; 2024 Apr; ():. PubMed ID: 38619006
[TBL] [Abstract][Full Text] [Related]
13. Investigation of imaging features in contrast-enhanced magnetic resonance imaging of benign and malignant breast lesions.
Kubota K; Fujioka T; Tateishi U; Mori M; Yashima Y; Yamaga E; Katsuta L; Yamaguchi K; Tozaki M; Sasaki M; Uematsu T; Monzawa S; Isomoto I; Suzuki M; Satake H; Nakahara H; Goto M; Kikuchi M
Jpn J Radiol; 2024 Mar; ():. PubMed ID: 38503998
[TBL] [Abstract][Full Text] [Related]
14. Comparative Investigation of Single Voxel Magnetic Resonance Spectroscopy and Dynamic Contrast Enhancement MR Imaging in Differentiation of Benign and Malignant Breast Lesions in a Sample of Iranian Women.
Faeghi F; Baniasadipour B; Jalalshokouhi J
Asian Pac J Cancer Prev; 2015; 16(18):8335-8. PubMed ID: 26745081
[TBL] [Abstract][Full Text] [Related]
15. Gadolinium-enhanced MR angiography of the breast: is breast cancer associated with ipsilateral higher vascularity?
Mahfouz AE; Sherif H; Saad A; Taupitz M; Filimonow S; Kivelitz D; Hamm B
Eur Radiol; 2001; 11(6):965-9. PubMed ID: 11419172
[TBL] [Abstract][Full Text] [Related]
16. Effect of contrast agent on T2-weighted fat-suppressed imaging and diffusion-weighted imaging in the diagnosis of breast tumors.
Li X; Ao Y; Mu L; Wang C; Zhao J; Chen H; Zhang S; Yang S; Zhang N; Qiu L
Quant Imaging Med Surg; 2024 May; 14(5):3655-3664. PubMed ID: 38720833
[TBL] [Abstract][Full Text] [Related]
17. Dynamic MR imaging of the breast combined with analysis of contrast agent kinetics in the differentiation of primary breast tumours.
Mussurakis S; Buckley DL; Drew PJ; Fox JN; Carleton PJ; Turnbull LW; Horsman A
Clin Radiol; 1997 Jul; 52(7):516-26. PubMed ID: 9240704
[TBL] [Abstract][Full Text] [Related]
18. Effects of contrast-enhancement on diffusion weighted imaging and apparent diffusion coefficient measurements in 3-T magnetic resonance imaging of breast lesions.
Cipolla V; Guerrieri D; Bonito G; Celsa S; de Felice C
Acta Radiol; 2018 Aug; 59(8):902-908. PubMed ID: 29110505
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic approach for dynamic breast MRI to indicate signal intensity time curves of benign and malignant lesions by using the tumor flow residence time.
Renz DM; Diekmann F; Schmitzberger FF; Pietsch H; Fallenberg EM; Durmus T; Huppertz A; Böttcher J; Bick U; Hamm B; Lawaczeck R
Invest Radiol; 2013 Feb; 48(2):69-78. PubMed ID: 23262793
[TBL] [Abstract][Full Text] [Related]
20. Contrast-enhanced 3.0-T breast MRI for characterization of breast lesions: increased specificity by using vascular maps.
Schmitz AC; Peters NH; Veldhuis WB; Gallardo AM; van Diest PJ; Stapper G; van Hillegersberg R; Mali WP; van den Bosch MA
Eur Radiol; 2008 Feb; 18(2):355-64. PubMed ID: 17882425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
